MedTrace Logo

GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers

NCT02179645 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2014-12-30

No results posted yet for this study

Summary

A Single Dose Study of GRC 27864 in Healthy Volunteers.

Conditions

  • Healthy

Interventions

DRUG

GRC 27864

DRUG

Celecoxib

DRUG

Placebo

Sponsors & Collaborators

  • Glenmark Pharmaceuticals S.A.

    collaborator INDUSTRY

  • Glenmark Pharmaceuticals Ltd. India

    lead INDUSTRY

Principal Investigators

  • Jim Bush, MB ChB · Medical Director

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02179645 on ClinicalTrials.gov